Andrew Ahmann
Overview
Explore the profile of Andrew Ahmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1840
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hessler D, Fisher L, Guzman S, Strycker L, Polonsky W, Ahmann A, et al.
Diabetes Care
. 2024 May;
47(8):1370-1378.
PMID: 38809903
Objective: To compare the effectiveness of three interventions to reduce diabetes distress (DD) and improve HbA1c among adults with type 1 diabetes (T1D). Research Design And Methods: Individuals with T1D...
2.
Garvey W, Cohen R, Butera N, Kazemi E, Younes N, Rosin S, et al.
Diabetes Care
. 2024 Jan;
47(4):562-570.
PMID: 38285957
Objective: To describe the individual and joint associations of baseline factors with glycemia, and also with differential effectiveness of medications added to metformin. Research Design And Methods: Glycemia Reduction Approaches...
3.
Parsiani R, Lundy R, Ahmann A, Joarder F, Castle J
J Am Pharm Assoc (2003)
. 2022 Sep;
62(6):1855-1859.
PMID: 36089458
Background: Diabetes is a complicated health condition that can lead to significant health complications. Pharmacists are in an ideal position to make therapeutic interventions, provide clinical education, and can provide...
4.
Barzilay J, Ghosh A, Busui R, Ahmann A, Balasubramanyam A, Banerji M, et al.
J Diabetes Complications
. 2021 Sep;
35(12):108047.
PMID: 34556408
Background: Studies examining whether measures of cognition are related to the presence of diabetic peripheral neuropathy (DPN) and/or cardiovascular autonomic neuropathy (CAN) are lacking, as are data regarding factors potentially...
5.
Jackson M, Ahmann A, Shah V
Diabetes Technol Ther
. 2021 Feb;
23(S1):S27-S34.
PMID: 33534631
The role of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) is well established in improving glycemic control and reducing hypoglycemia. Type 2 diabetes (T2D) is more prevalent than...
6.
Pratley R, Kanapka L, Rickels M, Ahmann A, Aleppo G, Beck R, et al.
JAMA
. 2020 Jun;
323(23):2397-2406.
PMID: 32543682
Importance: Continuous glucose monitoring (CGM) provides real-time assessment of glucose levels and may be beneficial in reducing hypoglycemia in older adults with type 1 diabetes. Objective: To determine whether CGM...
7.
Castle J, Rocha L, Ahmann A
J Diabetes Sci Technol
. 2020 May;
14(4):721-722.
PMID: 32443962
No abstract available.
8.
Fisher L, Hessler D, Polonsky W, Masharani U, Guzman S, Bowyer V, et al.
Diabetes Care
. 2018 Jul;
41(9):1862-1869.
PMID: 29976567
Objective: To compare the effectiveness of two interventions to reduce diabetes distress (DD) and improve glycemic control among adults with type 1 diabetes (T1D). Research Design And Methods: Individuals with...
9.
Beck R, Riddlesworth T, Ruedy K, Ahmann A, Haller S, Kruger D, et al.
Ann Intern Med
. 2017 Aug;
167(6):365-374.
PMID: 28828487
Background: Continuous glucose monitoring (CGM), which studies have shown is beneficial for adults with type 1 diabetes, has not been well-evaluated in those with type 2 diabetes receiving insulin. Objective:...
10.
McGill J, Ahmann A
Diabetes Technol Ther
. 2017 Jun;
19(S3):S3-S12.
PMID: 28585875
Continuous glucose monitoring (CGM) is developing into an increasingly useful tool for glucose monitoring and therapeutic guidance in the treatment of diabetes. Multiple daily doses of insulin (MDI) is the...